Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

ARMP

Armata Pharmaceuticals Inc

Apr 19 • 04:00PM ET

2.66

Dollar change +0.12
Percentage change 4.51	%

Healthcare • Biotechnology • USA • AMEX

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.91	Insider Own	70.35%	Shs Outstand	36.12M	Perf Week	-18.00%
Market Cap	96.34M	Forward P/E	-	EPS next Y	-1.30	Insider Trans	0.00%	Shs Float	10.72M	Perf Month	-24.72%
Income	-69.05M	PEG	-	EPS next Q	-0.31	Inst Own	3.63%	Short Float	0.13%	Perf Quarter	-31.67%
Sales	4.53M	P/S	21.27	EPS this Y	30.10%	Inst Trans	0.57%	Short Ratio	0.87	Perf Half Y	36.67%
Book/sh	-0.89	P/B	-	EPS next Y	2.62%	ROA	-63.39%	Short Interest	0.01M	Perf Year	70.83%
Cash/sh	0.37	P/C	7.13	EPS next 5Y	-	ROE	-3439.35%	52W Range	1.07 - 5.26	Perf YTD	-17.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	47.98%	ROI	-87.59%	52W High	-49.30%	Beta	0.97
Dividend TTM	-	Quick Ratio	1.16	Sales past 5Y	89.79%	Gross Margin	79.16%	52W Low	149.04%	ATR (14)	0.30
Dividend Ex-Date	-	Current Ratio	1.16	EPS Y/Y TTM	-76.58%	Oper. Margin	-902.85%	RSI (14)	31.57	Volatility	13.10% 9.01%
Employees	66	Debt/Eq	-	Sales Y/Y TTM	-17.77%	Profit Margin	-1524.51%	Recom	1.00	Target Price	8.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-92.17%	Payout	-	Rel Volume	0.59	Prev Close	2.55
Sales Surprise	81.90%	EPS Surprise	-92.98%	Sales Q/Q	45.39%	Earnings	Mar 21 AMC	Avg Volume	16.21K	Price	2.66
SMA20	-24.96%	SMA50	-24.33%	SMA200	-8.85%	Trades		Volume	9,559	Change	4.51%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-19-19	Initiated	Ladenburg Thalmann	Buy	$9

Mar-21-24 04:05PM	Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update (PR Newswire)
Mar-04-24 04:01PM	Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva (PR Newswire)
Feb-21-24 07:00AM	Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit (PR Newswire)
Nov-14-23 04:00PM	Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update (PR Newswire) +8.94%
Oct-30-23 08:00AM	Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference (PR Newswire) +10.19%
08:00AM	Loading…
Oct-19-23 08:00AM	Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023 (PR Newswire)
Sep-26-23 08:00AM	Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus (PR Newswire)
Sep-21-23 07:00AM	Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference (PR Newswire)
Aug-17-23 09:55AM	Armata Pharmaceuticals, Inc. (ARMP) Now Trades Above Golden Cross: Time to Buy? (Zacks)
Aug-14-23 07:00AM	Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update (PR Newswire)
Jul-11-23 08:00AM	Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics (PR Newswire)
May-31-23 08:00AM	Armata Pharmaceuticals Announces Oral Presentation Detailing Results from the Phase 1b/2a SWARM-P.a. Clinical Trial at the 6th World Conference on Targeting Phage Therapy (PR Newswire)
May-11-23 04:05PM	Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update (PR Newswire)
Mar-16-23 04:10PM	Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update (PR Newswire) +5.42%
Mar-06-23 06:00AM	Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a SWARM-P.a. Clinical Trial of Inhaled AP-PA02 in Patients with Cystic Fibrosis (PR Newswire) +10.87%
04:05PM	Loading…
Jan-10-23 04:05PM	Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC (PR Newswire) +25.38%
Dec-22-22 08:00AM	Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection (PR Newswire) -6.99%
Dec-08-22 09:55AM	Armata Pharmaceuticals, Inc. (ARMP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Nov-28-22 09:35AM	After Plunging 35.3% in 4 Weeks, Here's Why the Trend Might Reverse for Armata Pharmaceuticals, Inc. (ARMP) (Zacks)
08:00AM	Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage (PR Newswire)
Nov-15-22 09:55AM	Here's Why Armata Pharmaceuticals, Inc. (ARMP) Looks Ripe for Bottom Fishing (Zacks) -9.66%
Nov-09-22 04:15PM	Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update (PR Newswire)
Aug-11-22 04:05PM	Armata Pharmaceuticals Announces Second Quarter 2022 Results and Provides Corporate Update (PR Newswire)
Aug-01-22 08:00AM	Armata Pharmaceuticals Announces Clearance of IND for Prosthetic Joint Infections (PR Newswire)
May-23-22 08:00AM	Armata Pharmaceuticals Announces First Patient Dosed in Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia due to Staphylococcus aureus (PR Newswire)
May-12-22 04:17PM	Armata Pharmaceuticals Announces First Quarter 2022 Results and Provides Corporate Update (PR Newswire) -5.00%
Mar-31-22 04:05PM	Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $45 Million Private Placement with Innoviva (PR Newswire) -8.60%
Mar-22-22 10:00AM	Wall Street Analysts See a 52% Upside in Armata Pharmaceuticals, Inc. (ARMP): Can the Stock Really Move This High? (Zacks) +5.17%
Mar-17-22 04:05PM	Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update (PR Newswire) +5.37%
Mar-09-22 05:28PM	Armata Pharmaceuticals to move headquarters to Playa Vista (American City Business Journals)
08:00AM	Loading…
Feb-22-22 08:00AM	Armata Pharmaceuticals Announces Clearance of Investigational New Drug Application to Initiate Phase 2 Clinical Trial of AP-PA02 in Non-Cystic Fibrosis Bronchiectasis (PR Newswire)
Feb-17-22 08:00AM	Armata Pharmaceuticals to Participate in Two Upcoming Investor Conferences (PR Newswire)
Feb-09-22 04:16PM	Armata Pharmaceuticals Announces $45 Million Investment to Support Advancement of the Company's Bacteriophage Development (PR Newswire)
Jan-06-22 08:50AM	Recent Price Trend in Armata Pharmaceuticals, Inc. (ARMP) is Your Friend, Here's Why (Zacks) +7.12%
Jan-05-22 08:00AM	Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs (PR Newswire) +6.12%
Nov-29-21 10:00AM	Wall Street Analysts Believe Armata Pharmaceuticals, Inc. (ARMP) Could Rally 47%: Here's is How to Trade (Zacks) -17.62%
Nov-18-21 08:00AM	Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs (PR Newswire)
Nov-17-21 12:00PM	What Makes Armata Pharmaceuticals, Inc. (ARMP) a New Buy Stock (Zacks) +8.07%
Nov-10-21 04:05PM	Armata Pharmaceuticals Announces Third Quarter Results and Provides General Corporate Update (PR Newswire)
Nov-04-21 03:01PM	Armata Pharmaceuticals, Inc. (ARMP) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
08:00AM	Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress (PR Newswire)
Nov-02-21 08:00AM	Armata Enters Lease to Build State-of-the-Art R&D and GMP Manufacturing Facility (PR Newswire)
Oct-28-21 06:41PM	Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals (PR Newswire)
Sep-08-21 08:00AM	Armata Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
Aug-12-21 04:05PM	Armata Pharmaceuticals Announces Second Quarter Results and Provides General Corporate Update (PR Newswire)
Aug-05-21 03:00PM	Will Armata Pharmaceuticals, Inc. (ARMP) Report Negative Q2 Earnings? What You Should Know (Zacks)
Aug-02-21 07:30AM	Armata Pharmaceuticals Announces Chief Executive Officer Transition (PR Newswire)
Jul-07-21 07:30AM	Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference (PR Newswire)
May-13-21 04:05PM	Armata Pharmaceuticals Announces First Quarter Results and Provides General Corporate Update (PR Newswire)
10:45AM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Armata Pharmaceuticals Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors (PR Newswire)
Mar-18-21 04:05PM	Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update (PR Newswire)
Mar-17-21 04:01PM	Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 Million Private Placement with Innoviva (PR Newswire)
Mar-16-21 11:01AM	Armata Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference (PR Newswire)
Jan-27-21 07:01AM	Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs (PR Newswire)
Dec-09-20 07:30AM	Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors (PR Newswire)
Nov-16-20 11:10PM	Brokers Are Upgrading Their Views On Armata Pharmaceuticals Inc. (NYSEMKT:ARMP) With These New Forecasts (Simply Wall St.) -13.97%
Nov-15-20 07:17AM	Earnings Beat: Armata Pharmaceuticals Inc. (NYSEMKT:ARMP) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts (Simply Wall St.)
Nov-12-20 04:05PM	Armata Pharmaceuticals Announces Third Quarter 2020 Results and Provides General Corporate Update (PR Newswire) +7.95%
Oct-29-20 07:30AM	Armata Pharmaceuticals Issues Letter to Shareholders (PR Newswire) +7.00%
Oct-26-20 07:30AM	Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development (PR Newswire)
Oct-15-20 07:30AM	Armata Pharmaceuticals Announces Clearance of Investigational New Drug (IND) Application to Initiate Phase 1b/2a Clinical Trial of Lead Candidate AP-PA02 in Pseudomonas aeruginosa Infections (PR Newswire) +8.86%
Sep-29-20 07:30AM	Armata Pharmaceuticals to Present at the Virtual 2020 World Antimicrobial Resistance Congress (PR Newswire)
Sep-11-20 07:30AM	Armata Pharmaceuticals Announces Participation in Upcoming Investor Conferences (PR Newswire)
Aug-13-20 04:05PM	Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate Update (PR Newswire)
Jun-30-20 06:05AM	Here's Why We're Watching Armata Pharmaceuticals's (NYSEMKT:ARMP) Cash Burn Situation (Simply Wall St.)
Jun-17-20 07:30AM	Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Therapy to Treat S. aureus Bacteremia Infections (PR Newswire) +10.33%
May-14-20 04:05PM	Armata Pharmaceuticals Announces First Quarter 2020 Results and Provides General Corporate Update (PR Newswire)
Apr-28-20 08:00AM	Armata Pharmaceuticals to Participate in the Maxim Group M-Vest Infectious Disease Virtual Conference: The Renaissance of the Anti-Infective Sector (PR Newswire)
Mar-30-20 07:30AM	Armata Pharmaceuticals Announces Closing of Second Tranche of $25 Million Securities Purchase Agreement with Innoviva, Inc. (PR Newswire)
Mar-19-20 04:05PM	Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Results and Provides General Corporate Update (PR Newswire) -6.46%
Mar-18-20 08:00AM	Armata Pharmaceuticals Announces up to $5 Million Therapeutics Development Award from the Cystic Fibrosis Foundation (PR Newswire) +10.94%
Feb-13-20 08:00AM	Armata Pharmaceuticals Announces Closing of First Tranche of Recently Executed $25 Million Securities Purchase Agreement with Innoviva, Inc. (PR Newswire)
Jan-29-20 08:04AM	Company News For Jan 29, 2020 (Zacks) -26.80%
Jan-28-20 07:00AM	Armata Pharmaceuticals and Innoviva Announce $25 Million Strategic Investment to Support Advancement of Armata's Bacteriophage Development Programs (PR Newswire) +73.84%
Nov-12-19 04:05PM	Armata Pharmaceuticals Announces Third Quarter Results and Provides Corporate and Clinical Update (PR Newswire)
Oct-31-19 10:52AM	We're Keeping An Eye On Armata Pharmaceuticals's (NYSEMKT:ARMP) Cash Burn Rate (Simply Wall St.)
07:05AM	Armata Pharmaceuticals Issues Letter to Shareholders (PR Newswire)
Oct-21-19 07:05AM	Armata Pharmaceuticals Announces Receipt of $1.3 million R&D Tax Incentive (PR Newswire)
Oct-16-19 07:05AM	Armata Pharmaceuticals Strengthens Clinical Team with Appointment of Dr. Heather Dale Jones as Medical Director (PR Newswire)
Oct-10-19 04:05PM	Armata Pharmaceuticals Expands Board of Directors with the Appointment of Research and Development Veteran Todd C. Peterson, Ph.D. (PR Newswire)
Sep-19-19 07:05AM	Armata Pharmaceuticals to Participate in the Ladenburg Thalmann 2019 Healthcare Conference (PR Newswire)
Sep-12-19 09:00AM	Armata Pharmaceuticals Announces Development of New Synthetic Phage Candidate Targeting Pseudomonas aeruginosa (PR Newswire)
Aug-14-19 04:05PM	Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update (PR Newswire)
Aug-02-19 03:27PM	How Much Of Armata Pharmaceuticals, Inc. (NYSEMKT:ARMP) Do Institutions Own? (Simply Wall St.)
Aug-01-19 10:30AM	Armata Pharmaceuticals to Provide Corporate Update at the 39th Annual Canaccord Genuity Growth Conference (PR Newswire)
Jun-18-19 07:01AM	Armata Pharmaceuticals to Host Key Opinion Leader Meeting on Bacteriophage-Based Therapeutics on June 26 in New York (PR Newswire)
Jun-03-19 07:01AM	Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with New Patent Allowances in Europe and Canada (PR Newswire) -5.96%
May-28-19 07:01AM	Armata Pharmaceuticals Announces Publication of Successful Adjunctive Phage Treatment in Cystic Fibrosis Patient (PR Newswire) +31.67%

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ARMP

Armata Pharmaceuticals Inc

Upgrade your FINVIZ experience